Revelation Biosciences REVB
NASDAQ REVB
$3.66 -0.09 (-2.27%)
As of: Oct 21, 2026 · 10:56 AM EDT

Revelation Biosciences (REVB) Revenue (2025 - 2026)

Updated

Analysis

Revelation Biosciences (REVB) Revenue (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 25.31 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 16.99 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 15.03 Bn
10 Revelation Biosciences 14.03 Mn -34.99 Mn - 82,159.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82,159.00
Jun 30, 2025 19,672.00
API Access

Revelation Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=REVB&period=max&api_key=YOUR_API_KEY